Clinical Trial
Published on 13 Mar 2025
Quality of life improvements and clinical assessments in kidney transplant recipients undergoing pegloticase treatment for uncontrolled gout: findings of the phase 4 PROTECT clinical trial
in Alloimmunity and Transplantation
- 2,206 views
- 1 citation